This work provides a systematic review of the literature from January 2003 to April 2014
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the …

Objective: To determine the effect of two different weekly doses of folic acid on the toxicity
and efficacy of low-dose methotrexate therapy for rheumatoid arthritis. Design: Randomized, …

Thirty‐two patients with rheumatoid arthritis completed a 24‐week, placebo‐controlled,
double‐blind trial of folic acid (FA) supplementation during low‐dose methotrexate (MTX) therapy…

… As a nutrition fellow at the University of Alabama (UAB), where the work by Butterworth
and Weinsier was done, Sarah L. Morgan recognized an excellent opportunity to repeat the …

Osteonecrosis of the jaw (ONJ) has been associated with antiresorptive therapy in both
oncology and osteoporosis patients. This debilitating condition is very rare and advances in …

Dual-energy X-ray absorptiometry (DXA) is a technology that is widely used to diagnose
osteoporosis, assess fracture risk, and monitor changes in bone mineral density (BMD). The …

Objective To determine the effect of longterm methotrexate (MTX) therapy and folic acid
supplementation on folate nutriture and homocysteine levels in patients with rheumatoid arthritis. …

Many non-steroidal anti-inflammatory drugs (NSAIDs) (including sulphasalazine, sulindac,
indomethacin, naproxen, salicylic acid, ibuprofen, piroxicam and mefenamic acid) were found …

Background: The anti-folate drug methotrexate (MTX) is commonly used to treat rheumatoid
arthritis. Objective: To determine the allele frequencies of five common coding single-…

Dual-energy X-ray absorptiometry (DXA) is the gold standard for measuring bone mineral
density (BMD), making the diagnosis of osteoporosis, and for monitoring changes in BMD over …